Evolent Health, Inc. (NYSE:EVH) Receives $18.38 Average Price Target from Analysts

Shares of Evolent Health, Inc. (NYSE:EVH) have been given an average recommendation of “Buy” by the thirteen analysts that are currently covering the stock, MarketBeat reports. One investment analyst has rated the stock with a hold recommendation, eleven have issued a buy recommendation and one has issued a strong buy recommendation on the company. The average twelve-month price target among brokers that have covered the stock in the last year is $17.92.

A number of equities research analysts recently weighed in on the company. Stephens lowered their price target on Evolent Health from $16.00 to $12.00 and set an “equal weight” rating on the stock in a report on Tuesday, January 21st. Royal Bank of Canada lowered their price target on Evolent Health from $20.00 to $17.00 and set an “outperform” rating on the stock in a report on Tuesday, January 14th. BTIG Research lowered their price target on Evolent Health from $36.00 to $29.00 and set a “buy” rating on the stock in a report on Tuesday, December 3rd. Truist Financial lowered their price target on Evolent Health from $20.00 to $15.00 and set a “buy” rating on the stock in a report on Wednesday, January 22nd. Finally, JPMorgan Chase & Co. lowered their price target on Evolent Health from $15.00 to $13.00 and set an “overweight” rating on the stock in a report on Tuesday, January 28th.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in the business. Covestor Ltd increased its holdings in shares of Evolent Health by 138.1% during the 3rd quarter. Covestor Ltd now owns 1,424 shares of the technology company’s stock worth $40,000 after buying an additional 826 shares during the last quarter. GAMMA Investing LLC increased its holdings in shares of Evolent Health by 5,365.5% during the 3rd quarter. GAMMA Investing LLC now owns 1,585 shares of the technology company’s stock worth $45,000 after buying an additional 1,556 shares during the last quarter. Summit Creek Advisors LLC increased its holdings in shares of Evolent Health by 0.8% during the 4th quarter. Summit Creek Advisors LLC now owns 202,114 shares of the technology company’s stock worth $2,274,000 after buying an additional 1,636 shares during the last quarter. Creative Planning increased its holdings in shares of Evolent Health by 12.2% during the 2nd quarter. Creative Planning now owns 18,091 shares of the technology company’s stock worth $346,000 after buying an additional 1,973 shares during the last quarter. Finally, Pilgrim Partners Asia Pte Ltd acquired a new stake in Evolent Health in the 4th quarter valued at $26,000.

Evolent Health Stock Performance

NYSE EVH opened at $10.71 on Friday. The company has a current ratio of 1.04, a quick ratio of 1.04 and a debt-to-equity ratio of 0.58. The business’s 50 day moving average is $10.77 and its two-hundred day moving average is $18.92. Evolent Health has a 12-month low of $9.45 and a 12-month high of $35.00. The stock has a market capitalization of $1.25 billion, a price-to-earnings ratio of -11.77 and a beta of 1.45.

Evolent Health (NYSE:EVH) last released its earnings results on Thursday, February 20th. The technology company reported $0.03 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.38 by ($0.35). Evolent Health had a positive return on equity of 6.30% and a negative net margin of 2.93%. Research analysts expect that Evolent Health will post 0.22 EPS for the current year.

Evolent Health Company Profile

Evolent Health, Inc, through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients.